Literature DB >> 20870284

Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors.

Guoming Sun1, Yu-I Shen, Sravanti Kusuma, Karen Fox-Talbot, Charles J Steenbergen, Sharon Gerecht.   

Abstract

Slow vascularization of functional blood limits the transplantation of tissue constructs and the recovery of ischemic and wounded tissues. Despite the widespread investigation of polysaccharide-based hydrogel scaffolds for their therapeutic applications, blood vessel ingrowth into these hydrogel scaffolds remains a challenge. We hypothesized that modifying the properties of biodegradable hydrogel scaffolds with immobilization of multiple angiogenic growth factors (GFs) would induce a rapid proliferation of functional vasculature into the scaffolds. To this end, we remodeled the hydrogel structure by decreasing crosslinking density via reduced degree of substitution of crosslinking groups, which resulted in improved hydrogel properties including reduced rigidity, increased swelling, increased vascular endothelial GF (VEGF) release capability, and facilitated rapid hydrogel disintegration and tissue ingrowth. Immobilizing VEGF in the scaffolds promoted tissue ingrowth and expedited biodegradation. Furthermore, a synergistic effect of multiple angiogenic GFs was established; the coimmobilization of VEGF+ angiopoietin-1, and VEGF+ insulin-like GF+ stromal cell-derived factor-1 induced more and larger blood vessels than any individual GF, while the combination of all GFs dramatically increased the size and number of newly formed functional vessels. Altogether, our data demonstrate that rapid, efficient, and functional neovascularization can be achieved by precisely manipulating hydrogel scaffold properties and immobilizing defined angiogenic GFs.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870284     DOI: 10.1016/j.biomaterials.2010.08.091

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  31 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  Decellularized bovine placentome for portacavally-interposed heterotopic liver transplantation in rats.

Authors:  Zurab Kakabadze; Lia Karalashvili; David Chakhunashvili; Necat Havlioglu; Merab Janelidze; Ann Kakabadze; Yogeshwar Sharma; Sanjeev Gupta
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2018-12-10       Impact factor: 7.328

Review 3.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

4.  Collagen-gelatin mixtures as wound model, and substrates for VEGF-mimetic peptide binding and endothelial cell activation.

Authors:  Tania R Chan; Patrick J Stahl; Yang Li; S Michael Yu
Journal:  Acta Biomater       Date:  2015-01-10       Impact factor: 8.947

Review 5.  Engineering the vasculature for islet transplantation.

Authors:  Daniel T Bowers; Wei Song; Long-Hai Wang; Minglin Ma
Journal:  Acta Biomater       Date:  2019-05-23       Impact factor: 8.947

6.  Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels.

Authors:  Amy H Van Hove; Erin Antonienko; Kathleen Burke; Edward Brown; Danielle S W Benoit
Journal:  Adv Healthc Mater       Date:  2015-07-07       Impact factor: 9.933

Review 7.  Angiogenic biomaterials to promote therapeutic regeneration and investigate disease progression.

Authors:  Mai T Ngo; Brendan A C Harley
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

Review 8.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

9.  Integration and regression of implanted engineered human vascular networks during deep wound healing.

Authors:  Donny Hanjaya-Putra; Yu-I Shen; Abigail Wilson; Karen Fox-Talbot; Sudhir Khetan; Jason A Burdick; Charles Steenbergen; Sharon Gerecht
Journal:  Stem Cells Transl Med       Date:  2013-03-13       Impact factor: 6.940

Review 10.  Engineering dextran-based scaffolds for drug delivery and tissue repair.

Authors:  Guoming Sun; Jeremy J Mao
Journal:  Nanomedicine (Lond)       Date:  2012-11       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.